Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purchase price of USD 16.41 (ISK 2,250) per Share : vimarsana.com

Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purchase price of USD 16.41 (ISK 2,250) per Share

REYKJAVIK, Iceland, Feb. 26, 2024 -- Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has...

Related Keywords

China , Israel , Malaysia , South Africa , Yangtze River , China General , South Korea , Bangladesh , Cambodia , United States , Thailand , Taiwan , Vietnam , Republic Of , Reykjavik , C10 , Iceland , Japan , Australia , India , Hong Kong , Singapore , Philippines , Indonesia , Canada , New Zealand , Ukraine , Pakistan , Turkey , America , Robert Wessman , Abdi Ibrahim , Alvotech Manco , Oaktree Acquisition Corp , Pharma Corporation , Nasdaq Iceland Exchange , Lotus Pharmaceuticals Co Ltd , Alvotech Holdings , Globenewswire Inc , Global Communications , Teva Pharmaceutical Industries Ltd , European Parliament , Yangtze River Pharmaceutical Group Co Ltd , Council Directive , Kamada Ltd , Teva Pharmaceuticals , Fuji Pharma Co Ltd , Nasdaq Iceland , United States Securities Act , Teva Pharmaceutical Industries , Cipla Med Pro , River Pharmaceutical , Private Securities Litigation Reform Act , Note Regarding Forward Looking , Investor Relations , Markets ,